Hematologists Accepting MotivHealth Insurance CompanyPage 3

Shahzad Raza, MD

Staff Physician, Multiple Myeloma & AL Amyloidosis Program

Hematology

Carl Minniti, MD

Chief of the Division of Oncology & Hematology at Inspira Medical Center Mullica Hill

Hematology

Natalie Sinclair, MD

Director, Dana-Farber Brigham Cancer Center

Hematology

Tahir Latif, MD

Professor of Clinical Medicine; Director, Infusion Services UCMC

Hematology

Cristina Gasparetto, MD

Professor of Medicine

Hematology

Joseph McClure, MD

Hematology

Daniel Pollyea, MD

Clinical Director, Leukemia Services

Hematology

Julie Erika Haydu, M.D., PH.D.

Assistant Professor of Medicine

Hematology

Michael Seidman, MD

Hematology

Sarah Nikiforow, M.D., PH.D.

Technical Director, Immune Effector Cell Therapy Program

Hematology

April Chiu, M.D.

Associate Professor of Laboratory Medicine and Pathology

Hematology

Philip Saylor, M.D.

Assistant Professor of Medicine, Harvard Medical School

Hematology

Benjamin Schlechter, MD

Senior Physician in the Gastrointestinal Cancer Center at the Dana-Farber Cancer Institute with a particular focus on colorectal cancer, anal cancer, and innovative i; Director of Inpatient Hematology and Oncology there. He is an active participant in investigator-initiated, cooperative group, and industry funded clinical tr

Hematology

Andrew Evens, DO, MS

Deputy Director for Clinical Services and Chief Physician Officer, Rutgers Cancer Institute and Jack & Sheryl Morris Cancer Center; System Director of Medical Oncology and Oncology Lead, RWJBarnabas Health Medical Group; Associate Vice Chancellor for Clinical Innovation and Data Analytics, Rutgers Biomedical and Health Sciences

Hematology

Prabhsimranjot Singh, MD

Senior Physician; Instructor in Medicine, Harvard Medical School

Hematology

Girish Amin, MD

Hematologist-Oncologist

Hematology

Stephen Zrada, MD

Penn Medicine Clinician of Medicine

Hematology

William Berry, M.D.

Hematology

Michael Nissenblatt, MD

Chair with his wife Marlene for their leading annual fundraising event known as the ``Night of Wine and R

Hematology

David Peereboom, M.D.

Director, Clinical Research, Brain Tumor and Neuro-Oncology Center

Hematology